Jerzy Szaflarski

Jerzy Szaflarski practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Jerzy Szaflarski's NPI, 1275569014, was assigned on June 23, 2006. Jerzy Szaflarski holds Alabama license 31929.

Jerzy Szaflarski's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Jerzy Szaflarski's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Jerzy Szaflarski is also affiliated with UAB Hospital. The medical group on file is UAB Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Jerzy Szaflarski practices. Vendor and product names are available with a free account.

Neurology is Jerzy Szaflarski's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Jerzy Szaflarski is licensed in Alabama.

CMS data shows 192 Medicare services from Jerzy Szaflarski across 5 procedure codes in 2024, for 78 Medicare patients. Medicare paid $15,650 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 78 Medicare patients who saw Jerzy Szaflarski in 2024. The largest group is under 65, with 31 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jerzy Szaflarski's median patient age at 44, with 60% women.

In 2024, Jerzy Szaflarski wrote 1,213 Medicare Part D claims for 64 patients. 69% of them were for generic drugs. CMS names the drug for 1,110 of them, across 30 drugs with 11 or more claims each, at $926,797 in total drug cost. In 2023, CMS named 1,143 claims across 27 drugs.

Jerzy Szaflarski accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 267 papers to Jerzy Szaflarski, published from 2007 to 2025. 2021 was the busiest year, with 26. The most frequent topics are Magnetic Resonance Imaging, Seizures and Brain. Jerzy Szaflarski has published most often in Epilepsy Behav. Jerzy Szaflarski's most frequent co-authors are Elizabeth M. Bebin, Lawrence W. Ver Hoef and Michael D. Privitera, MD.

Dmand AI links Jerzy Szaflarski to 2 clinical trials. Conditions studied include Aphasia, Epilepsy, Post-Traumatic and Conversion Disorder.

CMS Open Payments shows 140 general payments to Jerzy Szaflarski from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 80% of the total. UCB, Inc. paid the most, $136,042. It also lists 24 research payments totaling $92,478 from 2016 to 2022.